@rodgardner87's blood work claims about TRT, fact-checked
Quick answer
The creator promotes a telehealth TRT service while disclosing a personal weekly testosterone dose of 350mg, which exceeds standard therapeutic ranges used to treat hypogonadism by clinical guidelines (Bhasin et al., 2018). The video demonstrates correct needle-switching technique and recommends pre-treatment blood work, but frames a supraphysiological dose as a personal reference point for an audience of men who have not yet been medically evaluated. Regulatory and safety concerns are significant given the platform's reach of nearly 500,000 views.
Our take · Written by FormBlends editorial team · Reviewed by FormBlends Medical Team· This is not a transcript. It is our independent review of the video above.
What did @rodgardner87 actually say?
Rod Gardner opens by disclosing he personally injects 350 milligrams of testosterone per week, then pivots to promoting Dynamic Three Health, a telehealth platform. He walks viewers through the kit they receive after signing up: a vial of testosterone, a 20-gauge needle to draw, and a 25-gauge needle to inject. He says he goes "intramuscular into the glue" (gluteal muscle) and invites anyone interested to comment "TRT" to receive a booking link for a physician appointment.
The video is clearly a paid or affiliate promotion. The hashtags include both #steroids and #trt, which is a telling combination. TRT is a legitimate medical treatment. Steroids is a bodybuilding term. Framing them as interchangeable is not an accident, and it matters.
Does the science back this up?
Some of what he describes is clinically accurate. The draw-and-switch needle technique is standard practice, and intramuscular gluteal injection is a legitimate administration route. The problem is the dose he casually discloses.
Clinical TRT guidelines from the American Urological Association (Mulhall et al., 2018, Journal of Urology) typically support doses in the range of 100 to 200 milligrams per week of testosterone cypionate or enanthate to restore physiological testosterone levels in hypogonadal men. The Endocrine Society's clinical practice guidelines (Bhasin et al., 2018, Journal of Clinical Endocrinology and Metabolism) align with this range, targeting mid-normal serum testosterone levels.
350 milligrams per week is not a therapeutic TRT dose by any clinical standard. It sits firmly in the range used in performance-enhancing and bodybuilding contexts. A study by Basaria et al. (2010, New England Journal of Medicine) found that supraphysiological testosterone doses were associated with increased cardiovascular adverse events. That is not a footnote risk.
What did they get wrong (or right)?
Credit where it is due: the needle gauge advice is correct. Drawing with a 20-gauge and injecting with a 25-gauge is standard technique that reduces injection site trauma. Gluteal IM injection is also a medically accepted route. And recommending blood work before starting is genuinely good advice, one of the few things in this video that belongs in a clinical conversation.
What is wrong, and plainly so, is the casual disclosure of a 350mg weekly dose as if it is a personal benchmark that incoming patients might reasonably expect. He says "I will document you the recommended dosage for you" based on blood work, but he has already anchored the audience to his own 350mg habit. That framing is misleading at best and dangerous at worst. There is no therapeutic justification for presenting a supraphysiological dose as a relatable starting point in a promotional video targeting people who have not yet been evaluated.
The caption's use of #steroids alongside #trt also blurs a line that regulated telehealth is supposed to maintain.
What should you actually know?
If you are considering TRT for symptoms of low testosterone, the actual clinical process looks like this: a physician orders serum testosterone levels (ideally measured on two separate mornings), evaluates symptoms, rules out secondary causes, and if treatment is warranted, starts at a conservative dose with follow-up labs in 6 to 12 weeks. The Endocrine Society defines hypogonadism as a consistent serum total testosterone below roughly 300 ng/dL alongside symptoms.
A dose of 350mg per week will almost certainly push testosterone levels far above the normal physiological range. Consequences of sustained supraphysiological testosterone include erythrocytosis (dangerously elevated red blood cell count), suppression of natural testosterone and sperm production, elevated estradiol, and cardiovascular strain. These are not rare edge cases. They show up routinely in lab work at those doses.
Getting blood work done before starting is the right first step. What you do with those results, and the dose you are prescribed, should come from a licensed physician reviewing your specific labs, not from a social media creator's personal injection habit.
Video review standard
Clinical fact-check snapshot
FormBlends treats social health videos as a starting point, then checks the claim against medical context, source quality, safety limits, and whether licensed provider review belongs in the next step.
Evidence signal
Source-backed review
Regulatory reality
Access rules depend on the compound and patient situation
Safety screen
Viral claims can miss contraindications, dose escalation, medication interactions, and quality-control risks.
This page currently connects to 9 source-backed evidence items through visible references or structured citation data.
PubMed evidence trail
Research sources used to frame this page
For @rodgardner87's blood work claims about TRT, fact-checked, FormBlends checks the page topic against primary trials, systematic reviews, guidelines, and current PubMed-indexed literature where available. These citations are context, not medical advice, proof of eligibility, or a claim that every study applies to every patient.
Cardiovascular Safety of Testosterone-Replacement Therapy
TRAVERSE trial anchor for cardiovascular-safety discussions in appropriately diagnosed men.
PubMed
Testosterone therapy in men with androgen deficiency syndromes: an Endocrine Society clinical practice guideline
Guideline anchor for diagnosis, monitoring, contraindications, and appropriate TRT framing.
PubMed
NAD+ metabolism and its roles in cellular processes during ageing
Core review for NAD+ decline, mitochondrial function, DNA repair, and aging biology.
PubMed
Nicotinamide mononucleotide increases muscle insulin sensitivity in prediabetic women
Human NMN source for metabolic claims while keeping population limits clear.
PubMed
Provider decision path
Use local research to choose a safer review path
Direct answer
@rodgardner87's blood work claims about TRT, fact-checked is best used to compare access, oversight, pricing, pharmacy quality, and patient support before starting care.
Evidence check
Directory pages should connect local intent with provider standards, pharmacy transparency, and practical next steps.
Safety check
Provider quality, pharmacy source, prescribing model, and follow-up support can matter as much as the medication name.
Next step
Compare providers, services and access requirements in the directory before contacting a suitable care team.
Claim path
Keep researching this testosterone and trt video claims cluster
Best for searchers turning TRT social claims into a safer lab-backed provider discussion.
Claim verdict
The useful answer behind this video
Claim being checked
The creator promotes a telehealth TRT service while disclosing a personal weekly testosterone dose of 350mg, which exceeds standard therapeutic ranges used to treat hypogonadism by clinical guidelines (Bhasin et al.
FormBlends verdict
The creator promotes a telehealth TRT service while disclosing a personal weekly testosterone dose of 350mg, which exceeds standard therapeutic ranges used to treat hypogonadism by clinical guidelines (Bhasin et al., 2018). The video demonstrates correct needle-switching technique and recommends pre-treatment blood work, but frames a supraphysiological dose as a personal reference point for an audience of men who have not yet been medically evaluated. Regulatory and safety concerns are significant given the platform's reach of nearly 500,000 views.
Patient-safe next step
Compare the claim with FormBlends safety guidance and a licensed-provider review before acting.
What to do with this video
Use the clip as a claim to verify, not a treatment plan
What it helps with
- The creator promotes a telehealth TRT service while disclosing a personal weekly testosterone dose of 350mg, which exceeds standard therapeutic ranges used to treat hypogonadism by clinical guidelines (Bhasin et al., 2018). The video demonstrates correct needle-switching technique and recommends pre-treatment blood work, but frames a supraphysiological dose as a personal reference point for an audience of men who have not yet been medically evaluated. Regulatory and safety concerns are significant given the platform's reach of nearly 500,000 views.
- Clinical TRT guidelines (Bhasin et al., 2018, Endocrine Society) support testosterone doses of roughly 100-200mg per week to restore normal physiological levels in hypogonadal men, not 350mg.
- 350mg per week of testosterone is a dose range associated with bodybuilding and performance enhancement, and Basaria et al. (2010, NEJM) linked supraphysiological testosterone to increased cardiovascular adverse events.
What it may miss
- It may not cover eligibility, contraindications, medication interactions, lab history, or dose escalation.
- Compound access, legal status, and product quality still need a separate safety check.
- Social video captions rarely show the full evidence base behind a claim.
Best next step
Compare the claim against a FormBlends guide, safety page, and licensed-provider review before acting.
Start provider reviewWhat You'll Learn
- Clinical TRT guidelines (Bhasin et al., 2018, Endocrine Society) support testosterone doses of roughly 100-200mg per week to restore normal physiological levels in hypogonadal men, not 350mg.
- 350mg per week of testosterone is a dose range associated with bodybuilding and performance enhancement, and Basaria et al. (2010, NEJM) linked supraphysiological testosterone to increased cardiovascular adverse events.
- The draw-with-20-gauge, inject-with-25-gauge needle technique shown in the video is clinically correct and reduces injection site trauma.
- Gluteal intramuscular injection is a legitimate and commonly used route for testosterone cypionate and enanthate administration.
- Pre-treatment blood work including serum testosterone (measured on two separate mornings) is genuinely recommended before starting TRT, per AUA guidelines (Mulhall et al., 2018).
- Sustained supraphysiological testosterone doses carry documented risks including erythrocytosis, estradiol elevation, suppression of the hypothalamic-pituitary-gonadal axis, and cardiovascular strain.
- Using both #trt and #steroids as hashtags in a telehealth recruitment post conflates a regulated medical treatment with performance-enhancing drug use, a distinction that matters clinically and legally.
Interested in GLP-1 or peptide therapy?
Get matched with licensed-provider review to help decide if it is right for you.
About the Creator
Rodgardner87 · TikTok creator
486.7K views on this video
Blood work can give you the answers to all your issues!! Dynamic3 understands and will help you on your health journey.. ⚕️#dynamic3health #steroids #trt
Sources & references
Citations extracted from our medical team's review. Click any citation to search PubMed.
Read More on This Topic
Our written guides go deeper with dosing details, comparison tables, and medical-team reviewed protocols.
Not medical advice. This video was made by Rodgardner87, not by FormBlends. Our write-up above is an editorial review, not a medical recommendation. Talk to your doctor before making any decisions about medications or treatments.